Smilagenin

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameSmilagenin
Drug Alias Name司迈吉宁IsosarsasapogeninSarsasapogenin斯马吉宁菝葜配基 +[13] 
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionBeta-nerve growth factor stimulants
TargetsBeta-nerve growth factor
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIxico Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhytopharm
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG